Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation.

[1]  P. Valent,et al.  Mast cell activation syndromes: definition and classification , 2013, Allergy.

[2]  P. Foster,et al.  A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. , 2013, The Journal of allergy and clinical immunology.

[3]  William Arbuthnot Sir Lane,et al.  Mast Cell Restricted Mouse and Human Tryptase·Heparin Complexes Hinder Thrombin-induced Coagulation of Plasma and the Generation of Fibrin by Proteolytically Destroying Fibrinogen* , 2012, The Journal of Biological Chemistry.

[4]  Y. Eishi,et al.  Basophils preferentially express mouse mast cell protease 11 among the mast cell tryptase family in contrast to mast cells , 2009, Journal of leukocyte biology.

[5]  F. Boehlen,et al.  "Heparinization" and hyperfibrinogenolysis by wasp sting. , 2009, The American journal of emergency medicine.

[6]  P. Kwok,et al.  Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations. , 2009, The Journal of allergy and clinical immunology.

[7]  Stuart M. Leon,et al.  Systemic mastocytosis as a rare cause of diffuse gastrointestinal hemorrhage. , 2009, The American surgeon.

[8]  J. Crish,et al.  Mast Cells Contribute to Autoimmune Inflammatory Arthritis via Their Tryptase/Heparin Complexes1 , 2009, The Journal of Immunology.

[9]  J. Morel,et al.  An unusual cause of spontaneous bleeding in the intensive care unit – mastocytosis: a case report , 2008, Cases journal.

[10]  I. Wicks,et al.  The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. , 2008, Arthritis and rheumatism.

[11]  N. Gattermann,et al.  Fatal Bleeding Due to a Heparin-Like Anticoagulant in a 37-Year-Old Woman Suffering From Systemic Mastocytosis , 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[12]  D. Friend,et al.  Mouse Mast Cell Tryptase mMCP-6 Is a Critical Link between Adaptive and Innate Immunity in the Chronic Phase of Trichinella spiralis Infection1 , 2008, The Journal of Immunology.

[13]  N. Trivedi,et al.  Mast Cell α and β Tryptases Changed Rapidly during Primate Speciation and Evolved from γ-Like Transmembrane Peptidases in Ancestral Vertebrates1 , 2007, The Journal of Immunology.

[14]  S. Thakurdas,et al.  The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections* , 2007, Journal of Biological Chemistry.

[15]  R. Adachi,et al.  Mast Cell-restricted Tryptases: Structure and Function in Inflammation and Pathogen Defense* , 2007, Journal of Biological Chemistry.

[16]  D. Friend,et al.  Lymphocyte-independent connective tissue mast cells populate murine synovium. , 2006, Arthritis and rheumatism.

[17]  J. Janc,et al.  Expression and characterization of recombinant ?-tryptase , 2006 .

[18]  G. Caughey.  Tryptase genetics and anaphylaxis. , 2006, The Journal of allergy and clinical immunology.

[19]  M. Mosesson.  Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.

[20]  E. Shen,et al.  Isolated prolongation of activated partial thromboplastin time following wasp sting. , 2005, Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi.

[21]  M. Tsai,et al.  Mast cells in the development of adaptive immune responses , 2005, Nature Immunology.

[22]  J. Marshall.  Mast-cell responses to pathogens , 2004, Nature Reviews Immunology.

[23]  M. Åbrink,et al.  Serglycin Is Essential for Maturation of Mast Cell Secretory Granule* , 2004, Journal of Biological Chemistry.

[24]  L. Schwartz,et al.  Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. , 2004, Biochemistry.

[25]  G. W. Wong,et al.  Mouse Chromosome 17A3.3 Contains 13 Genes That Encode Functional Tryptic-like Serine Proteases with Distinct Tissue and Cell Expression Patterns* , 2004, Journal of Biological Chemistry.

[26]  M. Samoszuk,et al.  Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer , 2003, International journal of cancer.

[27]  Hon J. Yu,et al.  Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin , 2003, Thrombosis and Haemostasis.

[28]  J. Bennett,et al.  Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. , 2003, Leukemia research.

[29]  Wei Zhao,et al.  Tryptase Precursors Are Preferentially and Spontaneously Released, Whereas Mature Tryptase Is Retained by HMC-1 Cells, Mono-Mac-6 Cells, and Human Skin-Derived Mast Cells 1 , 2003, The Journal of Immunology.

[30]  P. Foster,et al.  Biochemical and Functional Characterization of Human Transmembrane Tryptase (TMT)/Tryptase γ , 2002, The Journal of Biological Chemistry.

[31]  R. Huber,et al.  The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region. , 2002, Journal of molecular biology.

[32]  C. Malmsten,et al.  Genetic deficiency of human mast cell a‐tryptase , 2002 .

[33]  J. Hainfeld,et al.  Fibrinogen Assembly and Crosslinking on a Fibrin Fragment E Template , 2002, Thrombosis and Haemostasis.

[34]  T. Selwood,et al.  Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue differences at the S1 pocket. , 2002, Biochemistry.

[35]  J. Sodroski,et al.  Human Mast Cell Progenitors Can Be Infected by Macrophagetropic Human Immunodeficiency Virus Type 1 and Retain Virus with Maturation In Vitro , 2001, Journal of Virology.

[36]  K. Siebenlist,et al.  Protransglutaminase (Factor XIII) Mediated Crosslinking of Fibrinogen and Fibrin* , 2001, Thrombosis and Haemostasis.

[37]  Jonathan A. Ellman,et al.  Definition of the Extended Substrate Specificity Determinants for β-Tryptases I and II* , 2001, The Journal of Biological Chemistry.

[38]  J. Drazen,et al.  Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung* , 2001, The Journal of Biological Chemistry.

[39]  K. Lennert,et al.  Diagnostic criteria and classification of mastocytosis: a consensus proposal. , 2001, Leukemia research.

[40]  Hassan Mohammad Naif,et al.  Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. , 2001, Blood.

[41]  P. Wolters,et al.  Characterization of Human γ-Tryptases, Novel Members of the Chromosome 16p Mast Cell Tryptase and Prostasin Gene Families1 , 2000, The Journal of Immunology.

[42]  A. Jeffreys,et al.  Crossover breakpoint mapping identifies a subtelomeric hotspot for male meiotic recombination. , 2000, Human molecular genetics.

[43]  A. Sali,et al.  Formation of Enzymatically Active, Homotypic, and Heterotypic Tetramers of Mouse Mast Cell Tryptases , 2000, The Journal of Biological Chemistry.

[44]  A. Sali,et al.  Identification of a New Member of the Tryptase Family of Mouse and Human Mast Cell Proteases Which Possesses a Novel COOH-terminal Hydrophobic Extension* , 1999, The Journal of Biological Chemistry.

[45]  A. Sharpe,et al.  Heparin is essential for the storage of specific granule proteases in mast cells , 1999, Nature.

[46]  L. Hellman,et al.  Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme , 1999, Nature.

[47]  C. Huang,et al.  Human Tryptases α and β/II Are Functionally Distinct Due, in Part, to a Single Amino Acid Difference in One of the Surface Loops That Forms the Substrate-binding Cleft* , 1999, The Journal of Biological Chemistry.

[48]  M. Pallaoro,et al.  Characterization of Genes Encoding Known and Novel Human Mast Cell Tryptases on Chromosome 16p13.3* , 1999, The Journal of Biological Chemistry.

[49]  D. Johnson,et al.  Recombinant human mast cell tryptase beta: stable expression in Pichia pastoris and purification of fully active enzyme , 1998, Biotechnology and applied biochemistry.

[50]  R. Doolittle,et al.  Crystal structure of fragment double-D from human fibrin with two different bound ligands. , 1998, Biochemistry.

[51]  R. Huber,et al.  Human β-tryptase is a ring-like tetramer with active sites facing a central pore , 1998, Nature.

[52]  M. Stack,et al.  Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption. , 1998, Biochemistry.

[53]  D. Friend,et al.  Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. , 1998, Journal of immunology.

[54]  J. Abrahams,et al.  The anticoagulant activation of antithrombin by heparin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Sali,et al.  The Tryptase, Mouse Mast Cell Protease 7, Exhibits Anticoagulant Activity in Vivo and in Vitro Due to Its Ability to Degrade Fibrinogen in the Presence of the Diverse Array of Protease Inhibitors in Plasma* , 1997, The Journal of Biological Chemistry.

[56]  C. Baumgarten,et al.  Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. , 1997, Journal of immunology.

[57]  E. Davie,et al.  The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  A. Kessel,et al.  Vaginal bleeding ‐ a rare complication of immunotherapy , 1997, Allergy.

[59]  J. Whisstock,et al.  The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site. , 1997, Journal of molecular biology.

[60]  A. Sali,et al.  Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood , 1996, The Journal of experimental medicine.

[61]  K. Sakai,et al.  A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. , 1996, The Journal of clinical investigation.

[62]  K. Austen,et al.  Natural Disruption of the Mouse Mast Cell Protease 7 Gene in the C57BL/6 Mouse (*) , 1996, The Journal of Biological Chemistry.

[63]  L. Leach,et al.  Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. , 1995, Microvascular research.

[64]  Richard L. Stevens,et al.  Packaging of Proteases and Proteoglycans in the Granules of Mast Cells and Other Hematopoietic Cells , 1995, The Journal of Biological Chemistry.

[65]  D. Baltimore,et al.  Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor. , 1995, Immunity.

[66]  H. Pereira.  CAP37, a neutrophil‐derived multifunctional inflammatory mediator , 1995, Journal of leukocyte biology.

[67]  D. Friend,et al.  Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. , 1994, Journal of immunology.

[68]  D. Friend,et al.  Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[69]  M Karplus,et al.  Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes. , 1993, The Journal of biological chemistry.

[70]  E. Davie,et al.  The role of amino-terminal disulfide bonds in the structure and assembly of human fibrinogen. , 1993, Biochemical and biophysical research communications.

[71]  D. Gurley,et al.  Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[72]  C. Redman,et al.  Identification of B beta chain domains involved in human fibrinogen assembly. , 1992, The Journal of biological chemistry.

[73]  R. Stevens,et al.  The human serglycin gene. Nucleotide sequence and methylation pattern in human promyelocytic leukemia HL-60 cells and T-lymphoblast Molt-4 cells. , 1992, The Journal of biological chemistry.

[74]  G. Barton,et al.  Mast cell tryptases: Examination of unusual characteristics by multiple sequence alignment and molecular modeling , 1992, Protein science : a publication of the Protein Society.

[75]  C. Nathan,et al.  Complementary DNA sequence of human neutrophil azurocidin, an antibiotic with extensive homology to serine proteases. , 1991, Biochemical and biophysical research communications.

[76]  D. Gurley,et al.  Cloning of the cDNA and gene of mouse mast cell protease-6. Transcription by progenitor mast cells and mast cells of the connective tissue subclass. , 1991, The Journal of biological chemistry.

[77]  K. Siebenlist,et al.  The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin. , 1990, The Journal of biological chemistry.

[78]  L. Schwartz,et al.  Cloning and characterization of a second complementary DNA for human tryptase. , 1990, The Journal of clinical investigation.

[79]  S. M. Goldstein,et al.  Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[80]  C. Nathan,et al.  Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. , 1990, The Journal of clinical investigation.

[81]  L. Schwartz,et al.  Cloning and characterization of complementary DNA for human tryptase. , 1989, The Journal of clinical investigation.

[82]  L. Schwartz,et al.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. , 1989, The Journal of clinical investigation.

[83]  K. Siebenlist,et al.  Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[84]  G. Bruns,et al.  Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells. , 1988, The Journal of biological chemistry.

[85]  K. Austen,et al.  Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells , 1988 .

[86]  H. S. Earl,et al.  Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. , 1987, The New England journal of medicine.

[87]  C. Elson,et al.  Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. , 1987, Journal of immunology.

[88]  Welch Tr,et al.  Cutaneous mastocytosis with bleeding: probable heparin effect , 1987 .

[89]  D. Seldin,et al.  Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans. , 1986, Journal of immunology.

[90]  D. Atha,et al.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. , 1986, The Journal of biological chemistry.

[91]  L. Schwartz,et al.  Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. , 1986, The Journal of biological chemistry.

[92]  S. Galli,et al.  Anticoagulantly active heparin-like molecules from mast cell-deficient mice. , 1986, The American journal of physiology.

[93]  K. Austen,et al.  Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell. , 1985, The Journal of biological chemistry.

[94]  L. Schwartz,et al.  The fibrinogenolytic activity of purified tryptase from human lung mast cells. , 1985, Journal of immunology.

[95]  D. Seldin,et al.  Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells. , 1985, The Journal of biological chemistry.

[96]  A. Hjerpe,et al.  Glycosaminoglycans in rat mucosal mast cells. , 1985, The Biochemical journal.

[97]  E. Ruoslahti,et al.  Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[98]  H. Ris,et al.  Electron microscopy of fine fibrin clots and fine and coarse fibrin films. Observations of fibers in cross-section and in deformed states. , 1984, Journal of molecular biology.

[99]  K. Austen,et al.  Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate. , 1982, The Journal of biological chemistry.

[100]  K.,et al.  Tryptase from human pulmonary mast cells. Purification and characterization. , 1981, The Journal of biological chemistry.

[101]  D. Seldin,et al.  Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. , 1981, Journal of immunology.

[102]  I. Fabian,et al.  Increased uptake and desulphation of heparin by mouse macrophages in the presence of polycations. , 1978, Biochimica et biophysica acta.

[103]  B. Blombäck,et al.  A two-step fibrinogen–fibrin transition in blood coagulation , 1978, Nature.

[104]  K. Austen,et al.  Native heparin from rat peritoneal mast cells. , 1977, The Journal of biological chemistry.

[105]  D. Lagunoff,et al.  PROTEOLYTIC ENZYMES OF MAST CELLS * , 1963, Annals of the New York Academy of Sciences.

[106]  M. A. Zambonino,et al.  Metrorrhagia as an uncommon symptom of anaphylaxis. , 2010, Journal of investigational allergology & clinical immunology.

[107]  A. Walls,et al.  The heterogeneity of mast cell tryptase from human lung and skin. , 2003, European journal of biochemistry.

[108]  B. Orazi,et al.  Primary hyperfibrinogenolysis in a patient with anaphylactic shock. , 1994, Haematologica.

[109]  D. Lane,et al.  Heparin and Related Polysaccharides , 1992, Advances in Experimental Medicine and Biology.

[110]  L. Rodén,et al.  Heparin--an introduction. , 1992, Advances in experimental medicine and biology.

[111]  L. Schwartz,et al.  Interactions of human mast cell tryptase with biological protease inhibitors. , 1990, Archives of biochemistry and biophysics.

[112]  R. Rosenberg.  Heparin, antithrombin, and abnormal clotting. , 1978, Annual review of medicine.